GenVec Company Profile (NASDAQ:GNVC)

About GenVec

GenVec logoGenVec, Inc. (GenVec) is a clinical-stage biopharmaceutical company, engaged in the development of therapeutics and vaccines. The Company designs, tests and manufactures adenoviral-based product candidates. The Company's development programs address therapeutic areas, such as hearing loss and balance disorders, as well as vaccines against infectious diseases, including respiratory syncytial virus (RSV), herpes simplex virus (HSV), Enterovirus D68 (EV-D68) and malaria. In the area of animal health, it is developing vaccines against foot-and-mouth disease (FMD). The Company develops and commercializes its product candidates through collaborations. The Company's lead product candidate is CGF166. The Company's vaccine candidates include preventative vaccines against RSV and malaria, and a therapeutic vaccine for HSV. The Company is developing vaccine and anti-viral candidates for the prevention and containment of FMD outbreaks.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: GNVC
  • CUSIP:
Key Metrics:
  • Previous Close: $0.57
  • 50 Day Moving Average: $0.6117
  • 200 Day Moving Average: $0.6549
  • 52-Week Range: $0.35 - $3.69
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.83
  • P/E Growth: -0.0600
  • Market Cap: $13.01M
  • Outstanding Shares: 22,736,000
  • Beta: 2.16
Additional Links:
Companies Related to GenVec:

Analyst Ratings

Consensus Ratings for GenVec (NASDAQ:GNVC) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.10 (484.91% upside)

Analysts' Ratings History for GenVec (NASDAQ:GNVC)
DateFirmActionRatingPrice TargetDetails
7/26/2016Roth CapitalReiterated RatingBuy$8.00 -> $2.00View Rating Details
6/20/2016Rodman & RenshawReiterated RatingBuy$2.30View Rating Details
5/3/2016HC WainwrightReiterated RatingBuyView Rating Details
(Data available from 9/1/2014 forward)


Earnings History for GenVec (NASDAQ:GNVC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/5/2016Q116($0.10)($0.06)ViewN/AView Earnings Details
5/12/2016($0.09)($0.11)ViewN/AView Earnings Details
3/9/2016Q415($0.08)($0.10)ViewN/AView Earnings Details
8/7/2015Q215($0.10)($0.11)ViewN/AView Earnings Details
5/8/2015Q115($0.06)($0.09)ViewN/AView Earnings Details
3/24/2015Q414$0.08$0.11$3.33 million$3.50 millionViewListenView Earnings Details
11/12/2014Q314($0.11)($0.10)ViewN/AView Earnings Details
8/12/2014Q214($0.15)($0.10)ViewN/AView Earnings Details
5/12/2014Q114$0.04($0.07)$2.00 million$2.10 millionViewN/AView Earnings Details
3/28/2014Q413($0.16)($0.07)$1.52 million$0.15 millionViewListenView Earnings Details
11/12/2013Q313($0.23)$2.10 million$1.60 millionViewN/AView Earnings Details
11/9/2012Q312($0.32)($0.30)$2.90 million$2.13 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for GenVec (NASDAQ:GNVC)
Current Year EPS Consensus Estimate: $-0.29 EPS
Next Year EPS Consensus Estimate: $-0.29 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.09)($0.09)($0.09)
Q3 20161($0.09)($0.09)($0.09)
Q4 20161($0.09)($0.09)($0.09)
(Data provided by Zacks Investment Research)


Dividend History for GenVec (NASDAQ:GNVC)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for GenVec (NASDAQ:GNVC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/14/2015Douglas J SwirskyCEOBuy5,000$2.00$10,000.00View SEC Filing  
11/16/2015Stefan LorenDirectorBuy4,000$1.93$7,720.00View SEC Filing  
8/11/2015Douglas E BroughInsiderBuy4,600$2.34$10,764.00View SEC Filing  
5/27/2014Ecor1 Capital, LlcMajor ShareholderBuy24,140$2.24$54,073.60View SEC Filing  
3/28/2014Ecor1 Capital, LlcMajor ShareholderBuy122,273$2.55$311,796.15View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for GenVec (NASDAQ:GNVC)
DateHeadline logoGenVec, Inc. (NASDAQ:GNVC) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:GNVC) - August 26 at 8:15 AM logoGenVec faces delisting threat after it fails to raise share price (NASDAQ:GNVC) - August 25 at 5:18 PM logoGENVEC INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transf (NASDAQ:GNVC) - August 24 at 8:18 AM
News IconShares Spotted Gapping Up Pre-Bell: GenVec, Inc. (NASDAQ:GNVC) - Post News (NASDAQ:GNVC) - August 19 at 8:12 AM logoWill GenVec, Inc. (NASDAQ:GNVC) Hit $2.3 Price Target? - Investor Newswire (NASDAQ:GNVC) - August 19 at 8:12 AM
News IconStock Update on GenVec, Inc. (NASDAQ:GNVC) - Duncan Research (NASDAQ:GNVC) - August 12 at 8:21 AM logoGenVec, Inc. :GNVC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NASDAQ:GNVC) - August 9 at 4:03 PM logoGenVec Inc.: GenVec Reports Second Quarter 2016 Financial Results (NASDAQ:GNVC) - August 5 at 5:25 PM logoGenVec Reports Second Quarter 2016 Financial Results (NASDAQ:GNVC) - August 5 at 8:12 AM logoCan Shares Of GenVec, Inc. (NASDAQ:GNVC) Hit $2.3? - Investor Newswire (NASDAQ:GNVC) - July 29 at 12:25 PM
News IconBiotech news that matter for investors: GenVec (NASDAQ:GNVC), Achillion Pharmaceuticals (NASDAQ:ACHN) - The Voice Registrar (NASDAQ:GNVC) - July 27 at 8:01 AM
News IconVolatile Measures on Top- GenVec, Inc. (NASDAQ:GNVC), AerCap Holdings (NYSE:AER), First Data Corporation ... - Seneca Globe (NASDAQ:GNVC) - July 27 at 8:01 AM logoGenVec (GNVC) Says FDA Clinical Hold on CGF166 Phase 1/2 Lifted (NASDAQ:GNVC) - July 25 at 5:20 PM logoIs $8 Price Target Attainable For GenVec, Inc. (NASDAQ:GNVC)? - Investor Newswire (NASDAQ:GNVC) - July 22 at 8:10 AM
News IconGenvec Incorporated (NASDAQ:GNVC) Sellers Increased By 26.75% Their Shorts - Consumer Eagle (NASDAQ:GNVC) - July 20 at 6:40 PM
News IconGenvec Incorporated (NASDAQ:GNVC) Shorted Shares Decreased By 1.99% - Press Telegraph (NASDAQ:GNVC) - July 15 at 8:18 AM logoStrong Sell Calls For GenVec, Inc. (NASDAQ:GNVC) At 0 - Investor Newswire (NASDAQ:GNVC) - July 15 at 8:18 AM
News IconWatching Unusual Volume on Shares of: GenVec, Inc. (NASDAQ:GNVC) - Engelwood Daily (NASDAQ:GNVC) - July 12 at 5:32 PM logoIs $8 Within Reach For GenVec, Inc. (NASDAQ:GNVC)? - Investor Newswire (NASDAQ:GNVC) - July 8 at 8:07 AM logoBroker Outlook For GenVec, Inc. (GNVC) - Fiscal Standard (NASDAQ:GNVC) - July 7 at 8:05 AM
News IconCompany Stock Lower on the Week GenVec, Inc. (NASDAQ:GNVC) - Engelwood Daily (NASDAQ:GNVC) - July 4 at 4:55 PM logoBroker Outlook For The Week Ahead GenVec, Inc. (GNVC) - Fiscal Standard (NASDAQ:GNVC) - July 4 at 4:55 PM
News IconGenvec Incorporated (NASDAQ:GNVC) Shorts Decreased by 1.99% After Short Covering - Engelwood Daily (NASDAQ:GNVC) - July 2 at 8:11 AM logoGenVec, Inc. (NASDAQ:GNVC) Expected to Reach Highs Of $8 - Investor Newswire (NASDAQ:GNVC) - July 1 at 8:02 AM logoGenVec, Inc. (GNVC) Updated Price Targets - FTSE News (NASDAQ:GNVC) - June 30 at 8:05 AM logoNext Weeks Broker Price Targets For GenVec, Inc. (GNVC) - Fiscal Standard (NASDAQ:GNVC) - June 27 at 5:12 PM logoBrokers Issue Average Price Target Of 5.10 On GenVec, Inc. (GNVC) - FTSE News (NASDAQ:GNVC) - June 23 at 4:28 PM logoStrong Sell Calls Recommendations For GenVec, Inc. (NASDAQ:GNVC) At 0 - Investor Newswire (NASDAQ:GNVC) - June 23 at 4:28 PM logoGenVec, Inc. (GNVC) Current Analyst Ratings - Fiscal Standard (NASDAQ:GNVC) - June 22 at 5:23 PM logoGenVec Inc (NASDAQ:GNVC) target price bumped up to $2 as issued in a report today by Rodman & Renshaw (NASDAQ:GNVC) - June 22 at 9:54 AM logoGenVec Inc (NASDAQ:GNVC) target price bumped up to $2 as issued in a report today by Rodman & Renshaw - Breaking Finance News (NASDAQ:GNVC) - June 21 at 5:00 PM logoGenVec, Inc. (GNVC) Analyst Price Targets For The Coming Week - Fiscal Standard (NASDAQ:GNVC) - June 19 at 4:56 PM logoStrong Buy Calls Count For GenVec, Inc. (NASDAQ:GNVC) At 1 - Investor Newswire (NASDAQ:GNVC) - June 16 at 5:18 PM logoGENVEC INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (NASDAQ:GNVC) - June 2 at 11:22 AM
News IconInsiders Are Gradually Buying GenVec, Inc. (NASDAQ:GNVC) - HNN (NASDAQ:GNVC) - June 2 at 5:11 AM
News IconPerformance at a Glance on GenVec, Inc. (NASDAQ:GNVC) - HNN (NASDAQ:GNVC) - May 29 at 7:27 PM logoGenVec, Inc. (NASDAQ:GNVC) Impact Score At 0 - Investor Newswire (NASDAQ:GNVC) - May 29 at 7:27 PM logoNew Broker Ratings For GenVec, Inc. (GNVC) - FTSE News (NASDAQ:GNVC) - May 23 at 12:43 PM
News IconAfter Last Week What Do Analysts Think Of GenVec, Inc. (GNVC) - Share Trading News (NASDAQ:GNVC) - May 22 at 6:59 PM logoRevenue Update on GenVec Inc(NASDAQ:GNVC) - Trade Calls (NASDAQ:GNVC) - May 21 at 12:39 AM logoGenVec, Inc. :GNVC-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:GNVC) - May 17 at 12:49 PM logoGenVec, Inc. (NASDAQ:GNVC) One-Year Mean Price Target At $6.5 - Stocks Daily (NASDAQ:GNVC) - May 16 at 7:16 PM logoGenVec Reports First Quarter 2016 Financial Results (NASDAQ:GNVC) - May 12 at 8:17 AM logoGENVEC INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Fi (NASDAQ:GNVC) - May 10 at 5:48 PM logoGenVec, Inc. (NASDAQ:GNVC) ABR Of 1 - Stocks Daily (NASDAQ:GNVC) - May 9 at 1:18 AM
News IconNext Weeks Broker Price Targets For GenVec, Inc. (GNVC) - Share Trading News (NASDAQ:GNVC) - May 9 at 1:18 AM logoGenVec Announces $5 Million At-The-Market Offering (NASDAQ:GNVC) - May 5 at 9:21 AM logoGENVEC INC Financials (NASDAQ:GNVC) - March 12 at 1:04 PM logoGENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:GNVC) - March 9 at 8:01 AM logoGenVec Reports Fourth Quarter and 2015 Year-End Financial Results (NASDAQ:GNVC) - March 9 at 7:30 AM


GenVec (NASDAQ:GNVC) Chart for Thursday, September, 1, 2016

Last Updated on 9/1/2016 by Staff